Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

Clinical trial NCT05873322 · RECRUITING

Trial details

NCT number: NCT05873322
Sponsor: Aarhus University Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Precursor Cell Lymphoblastic Leukemia-Lymphoma Drug-Induced Diabetes Mellitus Impaired Glucose Tolerance Lymphoma

Start date: 2022-08-30
Primary completion: 2025-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.